Serum Androstenedione Test in Lahore at Chughtai Lab

Serum Androstenedione at Chughtai Lab

The Serum Androstenedione test is a highly specialized endocrine investigation that measures the concentration of androstenedione in the blood. Androstenedione is a steroid hormone classified as a weak androgen, serving as a critical intermediate precursor in the biosynthetic pathway of both male and female sex hormones. Synthesized primarily by the adrenal cortex (specifically within the zona reticularis) and the gonads (theca cells of the ovaries in females and Leydig cells of the testes in males), androstenedione is subsequently converted into more potent androgens, such as testosterone and dihydrotestosterone (DHT), as well as estrogens like estrone and estradiol. This conversion occurs through the enzymatic actions of 17-beta-hydroxysteroid dehydrogenase and aromatase in peripheral tissues. Consequently, measuring serum androstenedione levels provides invaluable clinical insights into the functional integrity of the steroidogenic pathways, adrenal gland activity, and gonadal health.

At Chughtai Lab, a premier diagnostic institution in Pakistan, this assay is performed using state-of-the-art automated immunoassay platforms or advanced liquid chromatography-tandem mass spectrometry (LC-MS/MS) technologies. These sophisticated methodologies ensure exceptional analytical sensitivity and specificity, which are essential for detecting the subtle hormonal fluctuations characteristic of endocrine disorders. The clinical utility of the Serum Androstenedione test spans across multiple medical specialties, including endocrinology, gynecology, pediatrics, and oncology. It serves as a cornerstone diagnostic tool for evaluating conditions characterized by androgen excess (hyperandrogenism), such as Polycystic Ovary Syndrome (PCOS), Congenital Adrenal Hyperplasia (CAH), and virilizing adrenal or ovarian tumors. By providing precise quantification of this precursor hormone, Chughtai Lab assists clinicians in establishing accurate diagnoses, formulating targeted treatment strategies, and monitoring therapeutic efficacy over time.

Clinical Procedure: What to Expect

Patient Preparation

Proper patient preparation is critical to minimize pre-analytical variability and ensure the clinical validity of the Serum Androstenedione test results. Patients must adhere to the following guidelines prior to sample collection:

• Diurnal Variation Considerations: Androstenedione levels exhibit a distinct diurnal rhythm, peaking in the early morning hours. Therefore, it is highly recommended that blood collection be performed between 7:00 AM and 10:00 AM.
• Menstrual Cycle Timing: For menstruating females, the timing of the test is highly significant. Unless otherwise directed by the referring physician, the sample should ideally be collected during the early follicular phase of the menstrual cycle (typically days 2 to 5 of the cycle) when baseline hormone levels are most stable.
• Medication Disclosure: Patients must inform their healthcare provider and the laboratory staff of all medications, supplements, and hormone therapies they are currently taking. Specifically, glucocorticoids, oral contraceptives, spironolactone, and any form of steroid or hormone replacement therapy can significantly alter androstenedione levels and may need to be temporarily discontinued under medical supervision.
• Fasting Guidelines: While strict fasting is not universally mandatory for a standalone androstenedione test, a fasting period of 8 to 12 hours is often recommended if the test is ordered as part of a comprehensive endocrine panel that includes lipid profiles or fasting glucose.
• Stress Reduction: Physical and emotional stress can stimulate the hypothalamic-pituitary-adrenal (HPA) axis, leading to transient elevations in adrenal androgens. Patients should rest quietly for 15 to 30 minutes before the blood draw.

During the Procedure

The Serum Androstenedione test is a straightforward outpatient laboratory procedure involving standard venipuncture. The process is conducted with the utmost care and professionalism at Chughtai Lab:

• Patient Identification and Verification: The phlebotomist will verify the patient’s identity using multiple identifiers and confirm compliance with preparation instructions, such as fasting and menstrual cycle timing.
• Aseptic Technique: The patient is seated comfortably, and the selected venipuncture site—typically the median cubital vein in the antecubital fossa of the arm—is thoroughly cleansed with an antiseptic solution (70% isopropyl alcohol) to prevent contamination.
• Sample Collection: A sterile, single-use needle is inserted into the vein, and blood is drawn into a serum separator tube (SST) or a plain red-top tube. The volume of blood collected is minimal, usually between 3 to 5 milliliters.
• Post-Venipuncture Care: Once the sample is obtained, the needle is gently withdrawn, and immediate pressure is applied to the puncture site with a sterile cotton swab to facilitate hemostasis. A protective adhesive bandage is then applied.
• Sample Processing: The collected blood is allowed to clot at room temperature before undergoing centrifugation to separate the serum from the cellular components. The isolated serum is then aliquoted and transported under temperature-controlled conditions to the analytical department for testing.
• Safety and Comfort: The entire venipuncture procedure takes less than five minutes. Patients may experience a mild, transient pinching sensation during needle insertion, but significant pain or complications are extremely rare.

When is a Serum Androstenedione Test Performed?

Evaluation of Polycystic Ovary Syndrome (PCOS)

Polycystic Ovary Syndrome is one of the most common endocrine disorders affecting reproductive-aged females. Clinicians frequently request a Serum Androstenedione test when a patient presents with clinical signs of hyperandrogenism, such as persistent acne, hirsutism (excessive male-pattern hair growth on the face, chest, or back), and androgenic alopecia (hair thinning). In PCOS, dysregulated luteinizing hormone (LH) secretion and insulin resistance stimulate the ovarian theca cells to overproduce androgens. Measuring androstenedione levels, alongside testosterone and dehydroepiandrosterone sulfate (DHEA-S), helps confirm the diagnosis of PCOS under the Rotterdam criteria, allowing for the differentiation of ovarian-derived androgen excess from adrenal pathologies.

Diagnosis of Congenital Adrenal Hyperplasia (CAH)

Congenital Adrenal Hyperplasia comprises a group of autosomal recessive disorders characterized by enzyme deficiencies in the adrenal steroidogenesis pathway, most commonly 21-hydroxylase deficiency. This enzymatic block prevents the efficient synthesis of cortisol, leading to compensatory hypersecretion of adrenocorticotropic hormone (ACTH) by the pituitary gland. The chronic overstimulation of the adrenal cortex causes an accumulation of precursor hormones, including 17-hydroxyprogesterone and androstenedione, which are shunted into the androgen synthesis pathway. The Serum Androstenedione test is crucial for diagnosing both classic (neonatal presentation with ambiguous genitalia or salt-wasting) and non-classic (late-onset presentation with premature adrenarche or hirsutism) forms of CAH.

Investigation of Hirsutism and Virilization

Virilization represents a severe manifestation of androgen excess in females, characterized by clitomegaly, deepening of the voice, increased muscle mass, and breast atrophy. When a patient exhibits rapid-onset hirsutism or signs of virilization, a Serum Androstenedione test is urgently indicated. These severe symptoms often point toward an underlying androgen-secreting neoplasm, such as an ovarian arrhenoblastoma, hilar cell tumor, or an adrenocortical carcinoma. By quantifying androstenedione levels in conjunction with other androgens, physicians can assess the severity of hyperandrogenism and determine whether the source of the excess hormone is primarily adrenal or gonadal, guiding subsequent imaging studies.

Assessment of Adrenal Tumors

Adrenal neoplasms, including benign adrenocortical adenomas and highly malignant adrenocortical carcinomas, can autonomously secrete large quantities of steroid hormones. A Serum Androstenedione test is performed as part of a comprehensive adrenal workup when an adrenal mass (incidentaloma) is detected on abdominal imaging. Markedly elevated levels of androstenedione, particularly when accompanied by high DHEA-S levels, strongly suggest an adrenal origin of hormone excess and raise suspicion for malignancy. Conversely, normal or mildly elevated levels may point toward a non-functioning adenoma, helping clinicians risk-stratify the patient and plan appropriate surgical or medical interventions.

Monitoring of Hormone Replacement and Suppression Therapy

For patients diagnosed with Congenital Adrenal Hyperplasia or other hyperandrogenic states, ongoing monitoring is essential to ensure therapeutic success. Clinicians utilize the Serum Androstenedione test to evaluate the efficacy of glucocorticoid replacement therapy, which aims to suppress excess ACTH secretion and normalize adrenal androgen production. Regularly monitoring androstenedione levels helps prevent both undertreatment (which leads to progressive virilization and accelerated bone age in pediatric patients) and overtreatment (which can cause Cushingoid side effects and growth suppression). The test is also valuable for monitoring patients undergoing anti-androgen therapy or ovarian suppression for severe PCOS.

What Does a Serum Androstenedione Detect?

The Serum Androstenedione test is highly sensitive to alterations in steroid hormone synthesis. It is capable of detecting, evaluating, and monitoring a wide range of clinical conditions, physiological states, and biochemical abnormalities, including:

• 21-Hydroxylase Deficiency: The most prevalent form of Congenital Adrenal Hyperplasia, leading to marked elevations in androstenedione.
• 11-Beta-Hydroxylase Deficiency: A less common form of CAH characterized by androgen excess and hypertension.
• 3-Beta-Hydroxysteroid Dehydrogenase Deficiency: A rare variant of CAH affecting both adrenal and gonadal steroid synthesis.
• Polycystic Ovary Syndrome (PCOS): Characterized by mild to moderate elevations in ovarian-derived androstenedione.
• Adrenocortical Carcinoma: A rare, aggressive malignancy associated with extremely high, autonomous secretion of androstenedione and DHEA-S.
• Adrenal Adenoma: Benign tumors of the adrenal cortex that may autonomously secrete androgens.
• Ovarian Arrhenoblastoma (Sertoli-Leydig Cell Tumor): A rare, virilizing ovarian neoplasm that produces high levels of androstenedione.
• Ovarian Hyperthecosis: A condition characterized by nests of luteinized theca cells in the ovarian stroma, leading to severe hyperandrogenism.
• Premature Adrenarche: The early onset of adrenal androgen secretion in children, presenting with early development of pubic hair and body odor.
• Precocious Puberty: Abnormally early onset of puberty in boys (before age 9) and girls (before age 8), which may be gonadotropin-dependent or independent.
• Cushing’s Syndrome: Adrenal-derived hypercortisolism that is frequently accompanied by elevated adrenal androgens, including androstenedione.
• Primary Adrenal Insufficiency (Addison’s Disease): Characterized by autoimmune destruction of the adrenal cortex, resulting in abnormally low levels of androstenedione.
• Secondary Adrenal Insufficiency: Pituitary dysfunction leading to deficient ACTH secretion and subsequent low adrenal androgen production.
• Hypopituitarism: Generalized loss of anterior pituitary hormones, causing secondary hypogonadism and adrenal insufficiency with low androstenedione levels.
• Menopausal Transition: Physiological decline in ovarian follicular function, leading to altered ratios of estrogens to androgens.
• Exogenous Steroid Abuse: Use of anabolic steroids which can suppress endogenous androstenedione production via negative feedback mechanisms.
• Glucocorticoid Therapy Compliance: Assessment of whether patients with CAH are taking their prescribed steroid dosages effectively.
• Hilar Cell Hyperplasia: A benign ovarian condition in postmenopausal women that can cause virilization due to elevated androstenedione.
• Idiopathic Hirsutism: Excessive hair growth in females with normal ovulatory cycles and normal or borderline-high androgen levels.
• Delayed Puberty: Investigation of the underlying cause of delayed sexual development in adolescents by assessing adrenal and gonadal biosynthetic capacity.

Turnaround Time and Report Access at Chughtai Lab

Chughtai Lab is widely recognized for its commitment to providing rapid, accurate, and highly reliable diagnostic services. For specialized endocrine assays such as the Serum Androstenedione test, the laboratory employs stringent quality control protocols to ensure precision. The typical turnaround time for the Serum Androstenedione test at Chughtai Lab is 24 to 48 hours from the time of sample collection. This efficient processing timeline ensures that referring physicians receive critical diagnostic data promptly, facilitating timely clinical decision-making.

To enhance patient convenience, Chughtai Lab offers multiple seamless methods for accessing test reports. Patients can download their electronic reports directly from the official Chughtai Lab website (myreport.chughtailab.com) by entering their patient ID and case number. Additionally, reports are accessible through the user-friendly Chughtai Lab Mobile App, available on both iOS and Android platforms, which maintains a secure digital archive of the patient’s diagnostic history. For added accessibility, Chughtai Lab also delivers reports directly via WhatsApp and offers physical report collection at any of its numerous, conveniently located collection centers across Pakistan, including major hubs in Lahore, Karachi, Islamabad, and Peshawar.

Serum Androstenedione Findings Overview

Structure / Parameter Evaluated	Normal Findings	Possible Abnormal Findings
Adult Males (18+ years)	0.6 – 2.7 ng/mL	Elevated: Adrenal/testicular tumors, CAH. Decreased: Hypogonadism, primary/secondary adrenal insufficiency.
Adult Females (Premenopausal)	0.3 – 3.3 ng/mL	Elevated: PCOS, CAH, ovarian hyperthecosis, virilizing tumors. Decreased: Adrenal insufficiency, ovarian failure.
Postmenopausal Females	0.2 – 1.0 ng/mL	Elevated: Ovarian stromal hyperplasia, hilar cell tumors. Decreased: Senile adrenal involution.
Prepubertal Children (1-10 years)	< 0.1 – 0.5 ng/mL	Elevated: Premature adrenarche, classic/non-classic CAH, precocious puberty.
Adrenal Cortex Function	Normal diurnal variation (morning peak); responsive to ACTH stimulation.	Hyperactivity: Adrenal hyperplasia, Cushing’s disease. Hypoactivity: Addison’s disease, bilateral adrenalectomy.
Ovarian Biosynthetic Pathway	Normal cyclic variation matching the menstrual cycle phases.	Dysregulation: LH-driven hyperandrogenism (PCOS), enzymatic blocks.
Testicular Biosynthetic Pathway	Stable baseline levels supporting normal spermatogenesis and virility.	Dysregulation: Leydig cell dysfunction, androgen insensitivity syndromes.
Therapeutic Suppression (CAH Patients)	Target levels maintained within the mid-to-lower normal reference range.	Subtherapeutic: Elevated androstenedione indicating inadequate glucocorticoid dosage.

Note: Diagnostic findings should always be interpreted by a qualified healthcare professional together with the patient’s symptoms, medical history, physical examination, laboratory investigations, previous imaging studies, and other relevant clinical information. Additional investigations or specialist consultation may be recommended depending on the findings.

Why Choose Chughtai Lab for Serum Androstenedione?

• Advanced Analytical Technology: Chughtai Lab utilizes state-of-the-art automated immunoassay analyzers and LC-MS/MS platforms, ensuring the highest level of precision and sensitivity for hormone detection.
• Expert Pathologists and Clinical Scientists: The laboratory is staffed by highly qualified, board-certified pathologists and clinical chemists who oversee all testing procedures and validate complex endocrine reports.
• ISO 15189 Certified Standards: Chughtai Lab adheres to rigorous international quality management systems, maintaining ISO 15189 certification across its primary diagnostic facilities.
• Convenient Home Sample Collection: Patients can avail themselves of Chughtai Lab’s highly professional home sample collection service, bringing sterile and reliable phlebotomy directly to their doorstep.
• Robust Internal and External Quality Control: The lab participates in prestigious external quality assurance programs, ensuring that test results are accurate and comparable to international standards.
• Seamless Digital Report Delivery: Patients and physicians can access secure electronic reports instantly via the Chughtai Lab mobile app, official website, or automated WhatsApp alerts.
• Extensive Nationwide Network: With hundreds of collection centers across Lahore and all major cities in Pakistan, accessing high-quality diagnostic services is exceptionally convenient.
• Patient-Centric Care and Support: Chughtai Lab is dedicated to providing a compassionate, comfortable, and professional environment for all patients, ensuring a stress-free diagnostic experience.